Through wound healing assays, we observed that reducing XTP6 expression significantly hindered the mobility of GBM cells (Fig. 2I, J), while its upregulation produced a contrary outcome (Fig. S1H, I). The gene discussed is DLEU1; the disease is glioblastoma.